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A B S T R A C T
Objective: To explore the in situ inflammatory proteins in the local extracellular fluid of infected bone tissue.
Material and methods: Seven pigs went through a two-step surgery performing a traumatically implant-associated
Staphylococcus aureus osteomyelitis in the proximal tibia. Five days later, microdialysis catheters (membrane cut
off: 20 kDa) were placed in the implant cavity, infected and healthy cancellous bone, and infected and healthy
subcutaneous tissue. Plasma samples were collected simultaneously. We employed an antibody-based proximity
extension assay (Olink Inflammatory panel) for the measurement of inflammatory molecules within plasma and
extracellular fluid of the investigated tissue compartments.
Results: A higher normalized protein expression in the infected bone tissue in comparison to healthy bone tissue
was identified for proteins associated with angiogenesis and bone remodeling: OPG, TGFα, MCP-1, VEGFA, and
uPA. Moreover, a parallel detectability of the systemic range of cytokines and chemokines as from the in-
vestigated local tissue compartments was demonstrated, indicating the same occurrence of proteins in the local
environment as within plasma.
Conclusion: An angiogenic and osteogenic inflammatory protein composition within the extracellular fluid of
infected bone tissue was described. The findings support the current histopathological knowledge and, therefore,
microdialysis may represent a valid method for sampling of material for protein investigation of the in vivo
inflammatory composition within the extracellular environment in infected bone tissue.
1. Introduction
Bacterial bone infections induce a massive inflammatory response.
However, the inflammatory composition in bone tissue emerged from
bacterial infections and its impact on the final healing outcome is
limited and the current knowledge is primarily based on in-vitro stu-
dies. Recently, it has been demonstrated that a bacterial induced in-
flammatory response was associated with reduced antibiotic bone pe-
netration in an acute implant-associated osteomyelitis porcine model
(Jensen et al., 2017b). Within the suppurative bone cavities, the his-
topathological changes comprised of extensive inflammatory processes
characterized by the presence of neutrophils, macrophages, osteoclasts,
activated fibroblasts, angiogenesis, oedema, and necrotic bone tissue
(Morawietz et al., 2006; Jensen et al., 2017b). Morphologically, these
changes are well described, whereas the in vivo biochemistry behind
the inflammatory response is poorly investigated (Morawietz et al.,
2006; Krenn et al., 2014; Jensen et al., 2017a; Jensen et al., 2017b). The
primary reason for this is the lack of a suitable method to assess the in
situ inflammatory processes through biochemical reactions. Micro-
dialysis, as a sampling method, has the potential to generate valuable in
vivo information regarding the inflammatory processes. Microdialysis is
advantaged by dynamic sampling of molecules from the extracellular
space and allows for simultaneous sampling from multiple tissues
(Muller, 2002; Joukhadar and Muller, 2005). Specifically for bone
tissue, microdialysis has until now mainly been applied for the assess-
ment of metabolism and antibiotics (Bogehoj et al., 2011; Lorenzen
et al., 2013; Tottrup et al., 2016; Bue et al., 2018b; Hanberg et al.,
2019; Tottrup et al., 2019). Antibody-based proximity extension assay
(PEA) is a specific and sensitive technique requiring only a small
amount of the target analyte within the sample in order to perform
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precision-, identification- and biomarker protein analysis (Lundberg
et al., 2011). The present study aimed to assess the feasibility of ap-
plying microdialysis and PEA as a tool for exploring inflammatory
molecules in the extracellular fluid of infected bone tissue. Further-
more, it was investigated if local tissue inflammatory proteins were
reflected in plasma samples.
2. Materials and methods
The study was approved by the Danish Working Environment
Authority and The Danish Animal Experiments Inspectorate, and was
carried out in accordance with existing laws (license No. 2013/15-
2934-00946). All biochemical analyses were performed at BioXpedia
A/S, Aarhus, Denmark. The study was performed on a previously de-
scribed porcine osteomyelitis model (Jensen et al., 2017a). The pigs
were included in a pharmacokinetic study of the vancomycin penetra-
tion into soft tissue, healthy bone tissue, infected bone tissue and in-
fected implant cavities (Bue et al., 2018a).
2.1. Study procedures
Seven female pigs (Danish Landrace breed, weighing from 75 to
86 kg) were included in the study. All pigs went through two surgeries:
day 0 and 5.
On day 0, a traumatically implant-associated Staphylococcus aureus
osteomyelitis was induced in the proximal metaphysis of the right tibia,
parallel to and approximately 10 mm distal to the epiphyseal line. A
concentration of 104 colony-forming units of a beta-hemolytic
Staphylococcus aureus strain S54F9 of spa type t1333 (spaserver.ridom.
de) in a 10-μL saline solution was inoculated in the cavity (ø: 4 mm,
depth 25 mm) with an implant of a 20 × 2 mm Kirschner wire
(Johansen et al., 2011; Aalbaek et al., 2015). Fluoroscopic and CT-
overview of surgical and sampling sites can be found elsewhere (Bue
et al., 2018a).
On day 5, all pigs had developed subcutaneous abscesses adjacent to
the implant cavity. In the infected leg, microdialysis catheters were
placed in the implant cavity, in a drill hole (ø: 2 mm, depth 25 mm)
approximately 8 mm parallel to the implant cavity and 10 mm distal to
the epiphyseal line (simulating infected cancellous bone), and in the
subcutaneous tissue parallel to and 10 mm distal to the skin incision
(simulating infected subcutaneous tissue). In the healthy left tibia,
microdialysis catheters were placed identically in a cancellous drill hole
and in subcutaneous tissue simulating healthy tissue. The following
membrane lengths of the microdialysis catheters were used: implant
cavity (20 mm), healthy and infected cancellous bone (20 mm), healthy
and infected subcutaneous tissue (30 mm). Correct location of the bone
catheters was assessed by fluoroscopy. A more profound description of
the surgical procedures can be found elsewhere (Tottrup et al., 2016;
Bue et al., 2018a).
One-thousand milligrams of vancomycin was given intravenously
and the first (time interval: 0–40 min) and last (time interval:
420–480 min) dialysate in a 8-h sampling period were collected from all
compartments from all pigs. Venous blood samples were drawn from a
central venous catheter in the middle of every dialysate sampling in-
terval. The dialysates were instantly stored at −80 °C until analysis.
Venous blood samples were stored at 5 °C for a maximum of 24 h before
being centrifuged at 3000g for 10 min. Plasma aliquots were then stored
at −80 °C until analysis. The pharmacokinetic vancomycin parameters
has previously been published (Bue et al., 2018a).
Induction of anesthesia on day 0 and 5 and postoperative care was
performed in standardized manner (Tottrup et al., 2016). During the
surgical procedures and the entire sampling period (day 5), the pigs
were kept under general anesthesia using a combination of fentanyl
(0.35–0.5 mg/h, continuous infusion) and propofol (500–600 mg/h,
continuous infusion). Core temperature and arterial pH was monitored
throughout the study and kept in the range of 36.2–39.1 °C and
7.36–7.47, respectively. Following collection of the last sample, the pigs
were euthanized using pentobarbital given intravenously.
2.2. Microdialysis
Briefly, microdialysis is a catheter-based method allowing for con-
tinuous sampling of molecules from the extracellular fluid in the tissue
of interest by means of a semipermeable membrane at the tip of the
microdialysis catheter (Muller, 2002; Joukhadar and Muller, 2005).
The solution that passes through the catheter can be sampled in small
vials for subsequent analysis. The microdialysis setup comprised of
CMA 107 precision pumps (μ-Dialysis AB, Stockholm, Sweden) and
CMA 70 catheters (molecular cut-off 20 kDa). All the microdialysis
catheters were perfused with 0.9% NaCl at a perfusion rate of 1 μL/min
throughout the sampling periods. Given the continuous perfusion of the
microdialysis system, complete concentration equilibrium across the
semipermeable membrane will never occur. Thus, the concentration in
the dialysate represents only a fraction of the absolute tissue con-
centration, expressed as relative recovery. A detailed description of
microdialysis can be found elsewhere (Muller, 2002; Joukhadar and
Muller, 2005; Hanberg et al., 2020).
2.3. Proximity extension assay
The first and last sample in the 8-h sampling period from all com-
partments from all pigs were used to estimate the local concentrations
of the protein profiles comprised in the Olink Inflammatory panel
(Olink proteomics) using a human PEA on a Fluidigm BioMark HD re-
altime polymerase chain reaction (PCR) platform. In brief, 1 μL sample
was used for PEA technology: an oligonucleotide-labeled antibody
probe was paired to the target protein and brought the oligos in
proximity for hybridization. A DNA polymerase was added for ampli-
fication and subsequently quantification was performed using micro-
fluidic real-time quantitative PCR (96.96 Dynamic Array™ Integrated
Fluidic Circuit (IFC) Fluidigm BioMark) (Lundberg et al., 2011;
Assarsson et al., 2014; Greenwood et al., 2015). Three replicates of
negative control and three replicates of interplate controls were run
together with the samples. Negative controls were used to determine
background levels and calculate assay specific limit of detection (LOD).
Interplate controls were used for calculation of normalized protein
expression (NPX). In addition, each assay contained four internal con-
trols to monitor all steps from incubation to detection(Assarsson et al.,
2014). The inflammatory panel allowed for analysis of 92 inflamma-
tion-related protein biomarkers across 96 samples simultaneously. A
comprehensive list of all protein markers can be found in Supplemen-
tary Fig. 1. Data are presented as arbitrary log2-transformed units NPX.
Higher NPX values correspond to a higher protein expression. Public-
access bioinformatic databases including UniProt, Gene Ontology,
KEGG pathways, and STRING were used for the interpretation of the
biological relevance of the differently expressed proteins.
2.4. Statistics
An explorative cut-off was created for the analysis of immunological
impact quantified in microdialysates and plasma specimens. Plasma
proteins with a data measured frequency below<80% were excluded
from statistical tests and only used descriptive. Proteins with higher
measured frequency in microdialysates in comparison to plasma were
included. In order to identify possible outliers, and to evaluate con-
sistency of the data, principal component analyses (PCAs) were per-
formed and visualized. PCA was performed for all samples grouped by
different variables of interest in R version 3.6.1. PCA plots were illu-
strated as scatterplots with percentage of variability. All NPX data were
checked for normality using histogram and QQ plots. All data are
presented as mean ± SE and differences between groups where con-
sidered significant when p < .05*. One-way ANOVA was performed on
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arbitrary log-2 scaled NPX values for microdialysates and plasma
comparison, and for healthy bone and infected bone comparison. The
statistical analyses were performed using STATA statistical Software:
release 13.1 (StataCorp LP, Collage Station, TX, USA).
2.5. Inter-group assessments
PEA was used for explorative assessment of the inflammatory pro-
tein composition differences in the following three collations; (1) local
(all microdialysates) vs systemtic (plasma), (2) healthy vs infected re-
cipients (both subcutaneous tissue and bone samples from healthy and
Fig. 1. Key proteins of interest from the microdialysates and plasma. (A) Selected proteins of interest based on measured microdialysate freq. or measured plasma
freq. (a) One-way ANOVA comparison between microdialysate and plasma. p-values< .05 were considered significant. (b) Not available information (n/a). (B)
Principal component analysis (PCA) of microdialysate and plasma samples. Analysis was based on NPXs of all proteins for each individual samples (smaller dots). The
ellipses indicate the percentage of variability by PC1 and PC2 using all individual samples for a given group. The colored ellipses denote 95% confidence intervals for
the different groups. Each axis is labeled with the percent total variance. The two labels correspond to microdialysates (red) and plasma (blue). (C) Biological
interaction of proteins measured in both microdialysates and plasma. Each description directs to a GO enrichment search p-value, involved partners, and GO terms.
(D) Graphic representation of proteins identified to have a connection within both groups. The same coloring indicates stronger relation. Data are extracted from
STRING version 10.5 (String-db.org). Protein and gene abbreviation of proteins with p-values< .05; T-cell surface glycoprotein Cd6 isoform, CD6; interleukin-1
alpha, IL-1 alpha; fibroblast growth factor 23, FGF-23; vascular endothelia growth factor A, VEGF-A; urokinase-type plasminogen activator, uPA (PLAU); monocyte
chemotactic protein 1, MCP-1; cystatin D, CST5; delta and notch-like epidermal growth factor-related receptor, DNER; protein S100-A12, EN-RAGE (S100A12);
transforming growth factor alpha, TGF-alpha (TGFA); matrix metalloproteinase-1, MMP-1; fibroblast growth factor 21, FGF-21; osteoprotegrin, OPG (TNFRSF11B).
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infected leg were included), and (3) healthy vs infected bone (infected
bone represents the cancellous bone compartment plus the implant
cavity as measurability was similar within the two compartments).
Data below LOD was not included in the analysis. The explorative
cut-off was used to locate the different protein measured frequency
across sample conditions. 19 plasma proteins exceeded the explorative
cut-off of data measured frequency > 80%, and 4 proteins in micro-
dialysates displayed higher measured frequency than that of plasma
(Fig. 1A). In total, 23 proteins were included for statistical tests.
3. Results
3.1. The explorative inflammatory profile in all microdialysates and plasma
Out of the 23 investigated proteins, 19 were associated with the
highest measured frequency in plasma (Fig. 1A). Four proteins; CD6, Il-
1α, FGF-23, and IL-12B had the highest detectability in microdialysates
(Fig. 1A). Among the explorative proteins that were excluded because
they were placed between 50% < plasma measurements< 80%
measured frequency were CD6, SCF, CXCL10, CD40, IL5 and CSF-1.
The possible associations among the explored proteins were visua-
lized in a principal component object score plot (Fig. 1B). The two
groups clustered separately and the groups differed in protein expres-
sion levels. Furthermore, there were four outliers placed close to or
outside the 95% confidence boundary of the microdialysates. A STRING
search was performed to data explore the putative target proteins in
plasma. A broad range of gene ontology (GO) terms (biological pro-
cesses) belonging to the immune response, leukocyte migration
(GO:0050900), angiogenesis (GO:0001525), and blood vessel mor-
phogenesis (GO:0048514) were identified but also cell mechanisms
were identified based on key proteins of interest (Fig. 1C). Biological
interactions between key proteins of interest are visualized in Fig. 1D.
Fig. 2 summarize the great dispersal of NPX values between micro-
dialysate and plasma. E.g., TGFα and MCP-1 (CCL2) did not dis-
criminate in NPX indicating the same measurability comparing local
versus systemic tissue fluid. CD6, Il-1α, and FGF-23 illustrate the same
measurability pattern as TGFα and MCP-1 but all proteins had a mo-
lecular weight larger than the microdialysis membrane cut off of 20 kDa
(Fig. 2 and 3A). Significant differences were seen for vascular en-
dothelia growth factor A (VEGFA), uPA, OPG, CST5, MMP1, and FGF21
between microdialysates and plasma with the highest NPX expression
in plasma (Fig. 2).
3.2. The incidence of inflammatory proteins in healthy and infected
recipients, and healthy and infected bone
The percentage of incidence for a given inflammatory protein be-
tween healthy and infected recipients, and healthy and infected bone
indicated similar incidence frequency. However, some inflammatory
proteins were more dominant in the infected compartments. The spe-
cific bone biomarker, OPG, was present in larger amounts in micro-
dialysate from infected bone compared with healthy bone (Fig. 3A).
The same tendency was observed with uPA and VEGFA (Fig. 1A and
3A). Furthermore, we observe a large heterogeneity within the protein
size from 11 kDa to 64 kDa (Fig. 3A). We found no significant difference
among the five compartments and the variance structure clusters more
intricate, as depicted by the PCA plot Fig. 3B.
Among the biological interactions observed in Fig. 1D, angiogenesis
displayed with four influencing partners such as VEGFA, urokinase-type
plasminogenactivator (PLAU), monocyte chemoattractant protein 1
(CCL2), and transforming growth factor alpha (TGFα). We assessed this
interaction in healthy bone and infected bone and observed a tendency
towards a higher NPX expression in infected bone but only TGFα de-
monstrated significance, p-value 2.10E-03, Fig. 3C.
4. Discussion
In infectious diseases, it is often difficult to anticipate the local
concentration of molecules or particular tissue homeostasis, as the
plasma level may not reflect the local environment or vice versa. The
importance of a specific local immune response in bone infections
seems logical as the blood supply is severely impaired during osteo-
myelitis. Recently, it was demonstrated that infected bone tissue pro-
duce a local up-regulation of acute phase proteins during bacterial bone
infection with no simultaneous expression of acute phase proteins in
liver and serum (Luthje et al., 2020). This explorative porcine study
appears to be the first study to investigate the local in vivo in-
flammatory response by means of microdialysis and PEA in an implant-
associated osteomyelitis model. The main finding was that micro-
dialysis was successfully applied for sampling of extracellular fluid
followed by assessment of in vivo inflammatory biomarkers by means of
PEA. Therefore, microdialysis is a representative method for future in
situ investigations of the local inflammatory proteins of complex tissues
such as bone tissue.
Surgical and drilling procedures introduce an obligate local in-
flammatory response. Nevertheless, a tendency of higher NPX in the
infected bone tissue in comparison to healthy bone tissue was identified
for proteins associated with angiogenesis and bone remodeling: OPG,
TGFα, MCP-1, VEGFA, and uPA. OPG is a bone biomarker and TGFα is a
known regulator of bone homeostasis balancing formation and resorp-
tion of bone, especially on osteoclast stimulation (Loi et al., 2016;
Luthje et al., 2018). MCP-1 (CCL2) is produced by macrophages and
monocytes and recognized to be involved in inflammation and phy-
siological bone remodeling (Siddiqui and Partridge, 2017). VEGFA and
uPA have convergent physiological events including angiogenesis
(Breuss and Uhrin, 2012). As both legs were subject to equal surgical
and drilling procedures, these differences are likely to be attributed to
the bacterial infection. Putting our findings into perspective, it is well
known that infection in bone induces intra-trabecular suppuration
which results in ischemic osseous sequestration and reduced vascular-
ization (Lew and Waldvogel, 1997). Therefore, it is reasonable to sug-
gest that the trend of higher expression level of angiogenic and bone
remodeling factors in infected bone found in the present study, is as-
sociated with regulation of tissue homeostasis balancing formation and
resorption of bone. As such, our present findings of the inflammatory
composition in infected bone tissue acknowledge the current literature
of the histopathological changes.
Our findings raise an interesting discussion regarding the origin of
the osteogenic- and angiogenic responses after inflammation and how it
is controlled. A local infection may retain the inflammatory response by
hindering systemic communication, but it may also be vice versa.
Although the presence of suppuration in bone may be the primary cause
of decreased antibiotic penetration and insufficient oxygen supply
(Tottrup et al., 2016; Jensen et al., 2017b; Bue et al., 2018a), local
angiogenic factors may be able to reach the systemic circulation. The
systemic circulation transports molecular substances to the local site of
inflammation, and in bone these substances pass from the capillary
walls into the interstitial fluid space of bone via fluid flux movement
(Piekarski and Munro, 1977; Cowin and Cardoso, 2015). We found that
some of the proteins, e.g. TGFα and MCP-1, were expressed equally
locally and systemically, others e.g. uPA and VEGFA exhibited higher
measurability in plasma, whereas e.g. CD6 and Il-1α displayed the
highest detectability in the microdialysates. We demonstrate parallel
detectability of the systemic range of cytokines and chemokines as from
the investigated local tissue compartments, indicating the same occur-
rence of molecules in the local environment as within plasma. However,
the implant is less tightly clustered than the other compartments, which
coincide with the low antibiotic penetration found in the implant
cavity, suggesting an environment of low penetration (Tottrup et al.,
2016; Jensen et al., 2017b; Bue et al., 2018a). From a future perspec-
tive, it could be speculated that some specific inflammatory proteins
M. Bue, et al. Bone Reports 13 (2020) 100292
4
convey to sole local comumnication, whereas other systemic in-
flammatory biomarkers may be able to reflect the local environment in
bone. Ultimately, this may allow for different monitoring approaches of
the infection progression within bone tissue.
The present study has a number of appreciable limitations.
Importantly, the microdialysate concentrations only allow for an ex-
plorative comparison to the absolute plasma concentrations. Due to a
perfusion rate of the microdialysis system of 1 μL/min, the protein re-
lative recovery was not 100% in this study setup, and f recovery was not
estimated. Therefore, the microdialysate results are underestimated in
the investigated local tissue compartments compared to plasma and can
only safely be regarded as representative of the changes in the con-
centrations ratios and the variation between compartments.
Furthermore, the membrane cut-off of 20 kDa excludes approximately
two thirds of the key protein from the Olink Inflammatory Panel.
However, we detected some molecules> 20 kDa, suggesting an inter-
stitial environment that bypasses the 20 kDa microdialysis membrane.
There may be several explanations to this, e.g. a high content of local
protein concentrations and locally degraded proteins. Furthermore, the
20 kDa membrane cut-off is only an approximation. For future in vivo
microdialysis studies assessing inflammatory markers in infected tis-
sues, the application of a higher cut-off membrane, a lower perfusion
flow rate, equal membrane lengths, different sampling intervals and
introduction of a systemic (intravenous) microdialysis catheter should
be considered. Finally, we applied a human PEA on porcine fluids. It is
difficult to evaluate the extent of this limitation, since the exact inter-
species differences of the investigated 92 inflammation-related protein
biomarkers are unknown. This may have resulted in unfitting PEA
Fig. 2. Normalized protein expression (NPX) of specific proteins associated with inflammation. Vertical axes represent arbitrary Log-2 scaled NPX. Horizontal axes
represent specific proteins from microdialysate and plasma. p-values< .05 are listed in Fig. 1A.
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antibody probes. Given the reproducibility of this porcine osteomyelitis
model, future development of coherent porcine PEAs will significantly
contribute in the understanding of the complex interplay of in vivo
inflammatory processes in bone infections.
5. Conclusion
In conclusion, this explorative study resulted in the finding of an
angiogenic and ostogenic inflammatory protein composition within
infected bone, in support of the current histopathological knowledge.
Microdialysis may represent a valid method for sampling of material for
protein investigation of the in vivo inflammatory composition within
Fig. 3. Key proteins of interest for healthy and infected recipients and in bone. (A) Proteins registered with a percentage of incidence>20 percentage for healthy and
infected recipients, and healthy and infected bone (B) Principal component analysis (PCA) of the five compartments; healthy cancellous bone, healthy subcutaneous
tissue, infected cancellous bone, infected subcutaneous tissue, and the implant cavity. Analysis was based on NPXs of all proteins for each individual sample (smaller
dots). The ellipses indicate the percentage of variability by PC1 and PC2 using all individual samples for a given group. The colored ellipses denote 95% confidence
intervals for the different groups. Each axis is labeled with the percent total variance. The five labels correspond to healthy cancellous bone (red), healthy sub-
cutaneous tissue (yellow), infected cancellous bone (green), infected subcutaneous tissue (blue), and the implant cavity (pink). (C) NPX of specific proteins associated
with angiogenesis for healthy cancellous bone and the infected bone compartments. Vertical axes represent arbitrary Log-2 scaled NPX. Horizontal axes represent
specific proteins from Healthy or infected Bone. p-values< .05 are considered significant.
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the extracellular environment in a rather complex tissue such as in-
fected bone tissue. To what extent the specific inflammatory protein
composition in bone tissue is involved in the pathological changes of
osteomyelitis, in the local and systemic inflammatory development, and
also the following regenerative response needs further investigation.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bonr.2020.100292.
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